Genmab (ADR) - GMAB - stock price prediction, stock price target, analyst ratings from 12 analysts

Genmab (ADR) has a share price target of US$ 44, revenue growth forecast of 21.1%, and profit growth estimate of -21.0% for FY26, based on top 12 analyst calls.